Posted on 10/7/19
Nevakar Enters Into $17.5M Product Financing Agreement with H.I.G. Capital Partners
Nevakar Inc., a specialty pharmaceutical company developing multiple assets in the ophthalmic and injectable areas
Posted on 10/7/19
Here's Why Sarepta Therapeutics Fell 16.5% in September
What happenedShares of Sarepta Therapeutics (NASDAQ:SRPT) slid over 16% last month, according to data from S&P Global Market Intelligence. The stock's September tumble was an extension . . .
Posted on 10/4/19
Bristol-Myers Squibb On Roll With Opdivo Results
SummaryOpdivo had positive trial results for esophageal cancer, melanoma, and non-small cell lung cancer.This should reassure investors that sales will continue to rise.Celgene shareholders benefit when . . .
Posted on 10/3/19
NanoView Biosciences and Alfatest Enter into Distribution Agreement
BOSTON--(BUSINESS WIRE)--NanoView Biosciences, Inc., and Alfatest today announced an exclusive distribution agreement for NanoView’s ExoView platform in Italy.“We believe that scientists in Italy will be excited . . .
Posted on 10/3/19
Goldfinch Bio Announces Licensing Agreement with Takeda
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a U.S.-based, clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced it . . .
Posted on 10/1/19
Constellation Pharmaceuticals Announces $65 Million Private Placement
CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop . . .
Posted on 9/30/19
Or-Genix Therapeutics and Fission Labs Announce Partnership
WORCESTER, Mass.--(BUSINESS WIRE)--Or-Genix Therapeutics, Inc., a development-stage specialty woman’s health and dermatology company, announced today that it has signed an agreement with Fission Labs LATAM, an . . .
Posted on 9/30/19
Vertex and Ribometrix Establish Strategic Collaboration
BOSTON & DURHAM, N.C.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and RNA therapeutics developer Ribometrix, Inc. announced today that the companies have entered into a strategic collaboration to . . .
Posted on 9/30/19
WebMD to Acquire Aptus Health
WebMD Health Corp., an Internet Brands company and the leader in health information services for consumers, physicians, and other healthcare professionals
Posted on 9/30/19
Boston Scientific Corporation (BSX) Management Presents at Investor Update at TCT 2019 (Transcript)
Boston Scientific Corporation. (NYSE:BSX) Investor Update at TCT 2019 September 27, 2019 3:00 PM ETCompany ParticipantsSusie Lisa - VP, IRLauren Tengler - Director Investor relationsJeff Mirviss . . .
Posted on 9/29/19
Cerveau Technologies Signs Research Agreement with Takeda
BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced a research collaboration agreement with Takeda Pharmaceutical Company Limited (Takeda), which will enable Takeda to use Cerveau’s [F-18]MK-6240, an investigational . . .
Posted on 9/26/19
Moderna Announces mRNA Immunotherapy Research Collaboration with Harvard University
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for . . .
Posted on 9/26/19
Harvard Pilgrim Health Care Provides $100,000 Grant to Boston Children’s Hospital for Adolescent Vaping Project
WELLESLEY, Mass.--(BUSINESS WIRE)--Harvard Pilgrim Health Care and Boston Children’s Hospital have announced their collaboration on an Adolescent Vaping Project to help doctors and counselors care for . . .
Posted on 9/26/19
Access Vascular Secures New Financing
Access Vascular, a medical device company developing the next generation of intravenous devices from novel biomaterials designed to minimize
Posted on 9/26/19
VBI Vaccines Announces Closing of Public Offering of Common Stock
CAMBRIDGE, Mass.--(BUSINESS WIRE)--VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the closing . . .
Posted on 9/26/19
Tetraphase Pharmaceuticals Announces Reverse Stock Split
WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (Nasdaq: TTPH), a biopharmaceutical company focused on commercializing its novel tetracycline XERAVATM (eravacycline for injection) to treat serious and life-threatening infections, . . .
Posted on 9/25/19
Thermo Fisher Scientific Prices Offering of Senior Notes
Thermo Fisher Scientific Inc. (NYSE: TMO) announced today that it has priced an offering of €4.4 billion aggregate principal amount of euro-denominated notes and an offering . . .
Posted on 9/25/19
XRHealth Partners with Allscripts
XRHealth, formerly known as VRHealth, the leader in extended reality and therapeutic applications, today announced a partnership with Allscripts to provide an integrated VR/AR platform, leveraging . . .
Posted on 9/25/19
Foundation Medicine and Natera Partner
Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA) today announced a partnership to develop and commercialize personalized circulating tumor DNA (ctDNA) monitoring assays, for use by . . .
Posted on 9/25/19
Mobile Heartbeat Collaborates With Eisenhower Health
WALTHAM, Mass.--(BUSINESS WIRE)--Healthcare communications company Mobile Heartbeat has announced a collaborative partnership with Magnet Recognized Eisenhower Health of Rancho Mirage, California. The aim of the partnership has . . .
Posted on 9/24/19
Foundation Medicine and Natera Partner
CAMBRIDGE, Mass. & SAN CARLOS, Calif.--(BUSINESS WIRE)--Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA) today announced a partnership to develop and commercialize personalized circulating tumor DNA . . .
Posted on 9/24/19
Disruptive Healthcare Brands ArmadaHealth, GetWellNetwork and GYANT Tap PAN Communications for Integrated PR Expertise
BOSTON--(BUSINESS WIRE)--PAN Communications, an integrated marketing and PR agency for B2B technology and healthcare brands, today announced it has been named agency of record for three . . .
Posted on 9/24/19
Warren Buffett's Investing Strategy, Explained By His Best Quotes
Warren Buffett is arguably the most respected investor of all time, and for good reason. In his 54-year tenure as CEO of Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) Buffett . . .
Posted on 9/24/19
Bioasis Announces Proposed Private Placement
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 TM platform technology for the delivery of therapeutics across the . . .
Posted on 9/23/19
Kymera Therapeutics is Named one of the FierceBiotech's "Fierce 15" Companies of 2019
Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create next generation medicines, today announced that it has been named by . . .

